title: MS pipeline flowing, but niche remains for neuroprotection.
authors: Hannah
authors: H
authors: Waters
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D040901:Proteomics
chemical_list: D007155:Immunologic Factors; D018696:Neuroprotective Agents